For citations:
Maltseva A.A., Kalinchuk A.Yu., Krakhmal N.V., Chernorubashkina N.M., Martynova E.S., Zukov R.A., Gofman A.A., Villert A.B., Churuksaeva O.N., Kolomiets L.A., Tashireva L.A. Tumor microenvironment parameters as a predictor of the duration of clinical effectiveness of immunotargeted therapy in advanced or metastatic endometrial cancer: A pilot multicenter observational study. Tumors of female reproductive system. 2024;20(1):114-123. (In Russ.) https://doi.org/10.17650/1994-4098-2024-20-1-114-123
Email this article 